Axio Biosolutions Private Limited - Due diligence report

A 360° intelligence report on Axio: trust score, financial health, credit view, compliance, directors, growth and distress signals - generat…

2008-05-16 Ahmedabad, Gujarat Active Unlisted Active Compliant
Share
AB Axio Biosolutions Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Axio — 360° Intelligence Report

Generated from MCA filings & public records
79/100
Trust Score
Low Risk

Axio is assessed as Low Risk with a Trust Score of 79/100. Axio is an active private limited indian non-government company incorporated in 2008, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Axio Biosolutions Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
79/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
71/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 3 satisfied (10.26 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Technology Development Board1 48.0 cr
Gvfl Trustee Company Private Limited1 48.0 cr
Compliance Score: 71/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • 1 auditor resignation(s) filed - latest: G. L. JAGETIA & CO. on 2018-02-12.
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
GOURAV JAGDISHCHANDRA MAHESHWARI 01234567 Director 01/04/2018 6 yrs Approved
LEO SEBASTIAN MAVELY 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Advamedica Inc
Subsidiaries
-
Group entities
-
Capital events
10 allotment(s) · 14 transfer(s)
Group entityRelationship% held
Advamedica Inc Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
Operating for 18+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 auditor resignation(s) on record - review the stated reasons.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view73/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
05 Jul 2025
Charge satisfied
Others
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
30 May 2023
Charge created
Others - 7.84 cr
13 Oct 2021
Securities allotted
490000 Equity Shares - 22.05 cr raised
11 Feb 2020
Securities allotted
575000 Equity Shares - 17.71 cr raised
26 Aug 2019
Director ceased
SEBASTIAN JOSEPH MAVELY
28 Sep 2018
Securities allotted
540000 Equity Shares - 10.80 cr raised
Director ceased
GOURAV JAGDISHCHANDRA MAHESHWARI
16 May 2018
Director appointed
GOURAV JAGDISHCHANDRA MAHESHWARI (Director)
21 Feb 2018
Director ceased
ARVIND MODI
31 Mar 2017
Share transfer (FY 2017)
11000.00000000 shares to ADVAMEDICA INC.
Share transfer (FY 2017)
5500.00000000 shares to ADVAMEDICA INC.
Share transfer (FY 2017)
5500.00000000 shares to BHAICHAND VISABHAI
Share transfer (FY 2017)
2200.00000000 shares to ADVAMEDICA INC.
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 10 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Shree Ganesh Fats Pvt Ltd U15142HP1994PTC014420 Himachal Pradesh, Himachal Pradesh, India
Ambic Ayurved U36912UP2010PTC042996 Meerut, Uttar Pradesh, India
Sri Balaji Agri Chem (India) Private Limited U24233TG2015PTC102079 Khairatabad, Telangana, India
Envitech Chemical Specialities Private Limited U24118PN2002PTC017155 Pune, Maharashtra, India
Mgr Medical Manufactures U74899HR1994PTC101612 Gurgaon, Haryana, India
Sarvothamcare U24110TG1995PLC020979 Secunderabad, Telangana, India
Kontest Chemicals Ltd U24119WB1972PLC028446 Kolkata, West Bengal, India
Highcare Hygiene Production Private Limited U24297RJ2021PTC077510 Shahpura, Rajasthan, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Axio before audits and certifications: compliance score 71/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Axio: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Axio - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 79/100, distress signals and MSME payment-delay disclosures - know whether Axio pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Axio - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Axio an active company?

Axio has MCA status “Active” with a compliance score of 71/100 (Moderate).

Is Axio financially healthy?

Axio has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Axio?

Its overall Trust Score is 79/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Axio?

The ultimate holding entity is Advamedica Inc. 2 active director(s) are on record.

Does Axio have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Axio up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 71/100 (Moderate).

Is it risky to lend to Axio?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.